other material
confidence high
sentiment neutral
materiality 0.50
Regen Biopharma increases authorized common shares to 5.8B; amends preferred share classes
Regen BioPharma Inc
- Authorized common shares increased from 4.8B to 5.8B, par value $0.0001.
- Series A Preferred authorized set at 540M shares; Series M Preferred at 60M shares.
- Total authorized capital includes 5.8B common, 540M Series A preferred, 60M Series M preferred.
- Amendment effective March 17, 2022.